Prevention and Control of Disease (Use of Vaccines) Regulation
L.N. 258 of 2020
B3921
B3921
L.N. 258 of 2020
Prevention and Control of Disease (Use of Vaccines) Regulation
Contents
Section
Page
| 1. | Commencement ............................................................................................................................................................................................................................................................................................................ |
B3923 |
| 2. | Interpretation ............................................................................................................................................................................................................................................................................................................ |
B3923 |
| 3. | Secretary may authorize vaccine for specified purpose ............................................................................................................................................................................................................................................................................................................ |
B3927 |
| 4. | Conditions of authorization ............................................................................................................................................................................................................................................................................................................ |
B3931 |
| 5. | Effective period of authorization ............................................................................................................................................................................................................................................................................................................ |
B3933 |
| 6. | Revocation of authorization ............................................................................................................................................................................................................................................................................................................ |
B3933 |
| 7. | Use of vaccine ............................................................................................................................................................................................................................................................................................................ |
B3935 |
| 8. | Authorized vaccine to be administered with informed consent ............................................................................................................................................................................................................................................................................................................ |
B3935 |
| 9. | Advisory panel ............................................................................................................................................................................................................................................................................................................ |
B3937 |
| 10. | Jurisdiction and immunity ............................................................................................................................................................................................................................................................................................................ |
B3939 |
| 11. | Certain notices are not subsidiary legislation ............................................................................................................................................................................................................................................................................................................ |
B3939 |
| 12. | Expiry ............................................................................................................................................................................................................................................................................................................ |
B3939 |
